Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q1 2024 (March 31)
6holders
$0.60avg. 13F price*

At the end of Q1 2024, 6 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings. The largest holders were LPL Financial LLC ($168K), Cowen and Company, LLC ($112K) and Sio Capital Management, LLC ($31K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions2$125K
Exits5$167K

Ownership 6 holders

LPL Financial LLC — Add +12.7% 280,599 $168K
Cowen and Company, LLC — New 187,213 $112K
Sio Capital Management, LLC — No change 49,998 $31K
Jane Street Group, LLC — No change 50,000 $30K
LMR Partners LLP — No change 49,279 $30K
Two Sigma Investments, LP — New 21,649 $13K

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.